CAREMIX
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

CAREMIX Trademark

Serial Number: 99551096

CAREMIX is a trademark filed by Fresenius Medical Care Deutschland GmbH on December 16, 2025. The trademark is classified under Class 7 (Machinery), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Fresenius Medical Care Deutschland GmbH (3 trademarks)

Else-Kröner-Str. 1
Bad Homburg 61352 , DE

Entity Type: 99

Trademark Details

Filing Date

December 16, 2025

Registration Date

Not Registered

Published for Opposition

October 6, 2026

Goods & Services

Business analysis and consulting for the optimization of existing infrastructure in dialysis clinics and medical facilities with regard to potential savings and efficient use of resources; business analysis and consulting for the optimization of existing technical building equipment and medical devices in dialysis clinics and medical facilities with regard to potential savings and efficient use of resources; technical consulting services in the field of energy efficiency in buildings, namely in dialysis clinics and medical facilities

Installation, repair, and maintenance of technical building equipment and medical devices in dialysis clinics and medical facilities; installation, repair, and maintenance work of business and office machinery and equipment resulting from business, scientific, technological, and engineering analysis to optimize technical building equipment and medical devices in dialysis clinics and medical facilities

Development and testing of the manufacture of dialysate concentrate; product quality testing and quality control for others; product quality authentication; technological, and engineering analysis and consulting with regard to energy efficiency in buildings, namely in dialysis clinics and medical facilities; technological, and engineering analysis and consulting with regard to the energy and resource efficiency of technical building equipment and medical devices in dialysis clinics and medical facilities; providing online nondownloadable computer software for remote monitoring and analysis of dialysis systems; installation, repair, and maintenance work of computer software resulting from business, scientific, technological, and engineering analysis to optimize technical building equipment and medical devices in dialysis clinics and medical facilities

Machines in the nature of central mixing plant for the production of dialysate concentrate

Remote video monitoring system consisting primarily of a camera and video monitor for recording and transmitting images to a remote location; downloadable computer software for remote monitoring and analysis of dialysis systems; downloadable computer software for use in the provision of intelligent gateways for data communication; downloadable computer software for use in the provision of intelligent gateways for data processing; downloadable computer software for use in the provision of intelligent gateways for real-time data analysis of dialysis systems

Hemodialysis apparatus in the nature of a distribution ring for medical purposes; medical devices for supplying dialysis media, concentrates and fluids for dialysis

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 2, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 12, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 12, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 21, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 7, 2026 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Mar 15, 2026 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 15, 2026 PARI
APPLICATION FILING RECEIPT MAILED
Jan 14, 2026 MAFR
NEW APPLICATION ENTERED
Dec 16, 2025 NWAP